A Study of ZD1839 Effects on Cell Proliferation in Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Gefitinib
Sponsor: AstraZeneca